Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

EBR:MELE - Euronext Brussels - BE0165385973 - Common Stock - Currency: EUR

69.825  -1.33 (-1.86%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MELE. MELE was compared to 51 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making MELE a very profitable company, without any liquidiy or solvency issues. MELE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MELE was profitable.
In the past year MELE had a positive cash flow from operations.
Each year in the past 5 years MELE has been profitable.
In the past 5 years MELE always reported a positive cash flow from operatings.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

With an excellent Return On Assets value of 19.17%, MELE belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
MELE has a better Return On Equity (30.21%) than 80.39% of its industry peers.
With an excellent Return On Invested Capital value of 23.13%, MELE belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MELE is significantly above the industry average of 15.31%.
The last Return On Invested Capital (23.13%) for MELE is well below the 3 year average (31.03%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROIC 23.13%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

MELE has a better Profit Margin (18.38%) than 62.75% of its industry peers.
MELE's Profit Margin has improved in the last couple of years.
MELE has a Operating Margin of 23.57%. This is in the better half of the industry: MELE outperforms 64.71% of its industry peers.
MELE's Operating Margin has improved in the last couple of years.
MELE has a Gross Margin (43.03%) which is comparable to the rest of the industry.
MELE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELE is creating value.
The number of shares outstanding for MELE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, MELE has more shares outstanding
Compared to 1 year ago, MELE has a worse debt to assets ratio.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.53 indicates that MELE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.53, MELE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
MELE has a debt to FCF ratio of 1.78. This is a very positive value and a sign of high solvency as it would only need 1.78 years to pay back of all of its debts.
The Debt to FCF ratio of MELE (1.78) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.38 indicates that MELE is not too dependend on debt financing.
The Debt to Equity ratio of MELE (0.38) is worse than 70.59% of its industry peers.
Even though the debt/equity ratio score it not favorable for MELE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Altman-Z 8.53
ROIC/WACC2.13
WACC10.87%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 4.54. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
MELE has a Current ratio of 4.54. This is amongst the best in the industry. MELE outperforms 84.31% of its industry peers.
A Quick Ratio of 2.01 indicates that MELE has no problem at all paying its short term obligations.
MELE has a better Quick ratio (2.01) than 72.55% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 2.01
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for MELE have decreased strongly by -32.50% in the last year.
The Earnings Per Share has been growing by 23.04% on average over the past years. This is a very strong growth
MELE shows a decrease in Revenue. In the last year, the revenue decreased by -9.03%.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-32.5%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-53.44%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-18.02%

3.2 Future

Based on estimates for the next years, MELE will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.99% on average per year.
Based on estimates for the next years, MELE will show a small growth in Revenue. The Revenue will grow by 4.75% on average per year.
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y9.99%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y4.75%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.78 indicates a rather expensive valuation of MELE.
Based on the Price/Earnings ratio, MELE is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.21, MELE is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 16.69, the valuation of MELE can be described as correct.
Based on the Price/Forward Earnings ratio, MELE is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MELE to the average of the S&P500 Index (21.70), we can say MELE is valued slightly cheaper.
Industry RankSector Rank
PE 19.78
Fwd PE 16.69
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MELE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MELE is cheaper than 64.71% of the companies in the same industry.
MELE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MELE is cheaper than 84.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.55
EV/EBITDA 11.45
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The excellent profitability rating of MELE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.86
EPS Next 2Y-0.54%
EPS Next 3Y4.79%

4

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 3.63%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.15, MELE pays a better dividend. On top of this MELE pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, MELE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

87.19% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP87.19%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (7/2/2025, 3:26:48 PM)

69.825

-1.33 (-1.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners15.6%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.82B
Analysts77.78
Price Target65.42 (-6.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP87.19%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.09%
Min EPS beat(2)-38.45%
Max EPS beat(2)-1.73%
EPS beat(4)1
Avg EPS beat(4)-9.23%
Min EPS beat(4)-38.45%
Max EPS beat(4)9.1%
EPS beat(8)4
Avg EPS beat(8)-4.63%
EPS beat(12)7
Avg EPS beat(12)-0.24%
EPS beat(16)10
Avg EPS beat(16)2.37%
Revenue beat(2)0
Avg Revenue beat(2)-4.03%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-2.93%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.68%
Revenue beat(8)1
Avg Revenue beat(8)-2.02%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)5.08%
PT rev (1m)4.44%
PT rev (3m)-2.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 19.78
Fwd PE 16.69
P/S 3.02
P/FCF 22.55
P/OCF 15.83
P/B 4.97
P/tB 4.98
EV/EBITDA 11.45
EPS(TTM)3.53
EY5.06%
EPS(NY)4.18
Fwd EY5.99%
FCF(TTM)3.1
FCFY4.43%
OCF(TTM)4.41
OCFY6.32%
SpS23.09
BVpS14.05
TBVpS14.02
PEG (NY)N/A
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROCE 27.83%
ROIC 23.13%
ROICexc 24.13%
ROICexgc 24.17%
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
FCFM 13.41%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexcg growth 3Y-14.81%
ROICexcg growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score5
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Debt/EBITDA 0.8
Cap/Depr 111.24%
Cap/Sales 5.69%
Interest Coverage 20.46
Cash Conversion 66.58%
Profit Quality 72.96%
Current Ratio 4.54
Quick Ratio 2.01
Altman-Z 8.53
F-Score5
WACC10.87%
ROIC/WACC2.13
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.5%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-53.44%
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y9.99%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-18.02%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y4.75%
EBIT growth 1Y-15.83%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-15.16%
EBIT Next 3Y8.75%
EBIT Next 5Y10.24%
FCF growth 1Y236.29%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y5817.76%
OCF growth 3Y7.8%
OCF growth 5Y13.55%